title: Mapping SLCO1B1 Genetic Variation for Global Precision Medicine in Understudied Regions in Africa: A Focus on Zulu and Cape Admixed Populations.
abstract: The U.S. President Barack Obama has announced, in his State of the Union address on January 20, 2015, the Precision Medicine Initiative, a US$215-million program. For global precision medicine to become a reality, however, biological and environmental "variome" in previously understudied populations ought to be mapped and catalogued. Chief among the molecular targets that warrant global mapping is the organic anion-transporting polypeptide 1B1 (OATP1B1), encoded by solute carrier organic anion transporter family member 1B1 (SLCO1B1), a hepatic uptake transporter predominantly expressed in the basolateral side of hepatocytes. Human OATP1B1 plays a crucial role in the transport of a wide variety of substrates. This includes endogenous compounds such as bile salts as well as medicines, including benzylpenicillin, methotrexate, pravastatin, and rifampicin, and natural toxins microcystin and phalloidin. Genetic variations observed in the SLCO1B1 gene have been associated with altered in vitro and in vivo OATP1B1 transport activity, and consequently influencing patients' response to medicines, toxins, and susceptibility to common complex diseases. Well-characterized haplotypes, *5 (RS4149056C) and *15 (RS4149056T), have been associated with a strikingly reduced uptake of multiple OATP1B1 substrates, including estrone-3-sulfate, estradiol-17β-d-glucuronide, atorvastatin, cerivastatin, pravastatin, and rifampicin. In particular, RS4149056C is observed in 60% of the Cape admixed (CA) population and is associated with increased plasma concentrations of many statins as well as fexofenadine and repaglinide. We designed and optimized a SNaPshot minisequencing panel to characterize the variants of relevance for precision medicine in the clinic. We report here the first study on allele and genotype frequencies for 10 nonsynonymous, 4 synonymous, and 6 intronic single-nucleotide polymorphisms of SLCO1B1 in the Zulu and CA populations of South Africa. These variants are further contextualized here, in relation to their potential clinical relevance. These observations collectively contribute to current efforts to advance global precision medicine in understudied populations and resource-limited regions of the world.
authors.affiliation: Pharmacogenetics Laboratory, Department of Biotechnology, Faculty of Natural Science, University of the Western Cape , Bellville, South Africa .
authors.forename: Nisreen
authors.initials: N
authors.lastname: Hoosain
authors.affiliation: Pharmacogenetics Laboratory, Department of Biotechnology, Faculty of Natural Science, University of the Western Cape , Bellville, South Africa .
authors.forename: Brendon
authors.initials: B
authors.lastname: Pearce
authors.affiliation: Pharmacogenetics Laboratory, Department of Biotechnology, Faculty of Natural Science, University of the Western Cape , Bellville, South Africa .
authors.forename: Clifford
authors.initials: C
authors.lastname: Jacobs
authors.affiliation: Pharmacogenetics Laboratory, Department of Biotechnology, Faculty of Natural Science, University of the Western Cape , Bellville, South Africa .
authors.forename: Mongi
authors.initials: M
authors.lastname: Benjeddou
mesh_terms: D000483:Alleles; D002874:Chromosome Mapping; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D004970:Estrone / Q000031:analogs & derivatives* / Q000494:pharmacology; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D027381:Liver-Specific Organic Anion Transporter 1 / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D057285:Precision Medicine; D013019:South Africa
chemical_list: D027381:Liver-Specific Organic Anion Transporter 1; C503999:SLCO1B1 protein, human; C025483:estradiol-17 beta-glucuronide; D004970:Estrone; D004958:Estradiol; C017296:estrone sulfate